Our findings unequivocally established that age, β2M level ≥ 5.5 mg/L, LDH level ≥ 300 μ/L, and the risk score itself emerged as independent prognostic indicators for MM patients. The gene discussed is B2M; the disease is Miyoshi myopathy.